Nutritional therapy / dietitian
What studies of nutritional therapy / dietitian found
At a glance, by condition
ME/CFS: D Little or no difference
Based on the strongest evidence, compared with another group, not randomised (very low certainty), for overall symptoms.
1 outcome rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: Studies found little or no difference with nutritional therapy / dietitian for ME/CFS. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- CMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- Nutritional therapy / dietitian · ME/CFS is hereDLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
ME/CFS
Daily life and health overall
Overall symptoms1 study · 27 people took nutritional therapy / dietitian Little or no difference D
Why this grade: Little or no difference, very low certainty, from controlled studies: serious risk of bias (ROBINS-I); the change wasn't shown to be more than chance; only people who finished were analysed.
Compared with another group, not randomised145 in the study · 142 started · 138 with outcome data · 3 months · an initial 1 h evaluation and a follow-up approximately every 6 weeks; minimum of two 1 h sessions with email support
No clear difference in overall symptoms.
The evidence is very uncertain about the effect of Nutritional therapy / dietitian on overall symptoms in ME/CFS. Little or no difference · very low certainty D
- Serious risk of bias (ROBINS-I)
- The change wasn't shown to be more than chance
- Only people who finished were analysed
See the 1 study
-
- People in the study
- 145 in the study · 142 started · 138 with outcome data
- Dose
- an initial 1 h evaluation and a follow-up approximately every 6 weeks; minimum of two 1 h sessions with email support
- Outcome
- change scores between the three groups
- Effect
- no clear difference
- Risk of bias
ROBINS-I: Serious
- Confounding
- Moderate. adjusted for: baseline variation between groups (analysis of covariance); Bonferroni correction for multiple post hoc comparisons
analysis of covariance tests were used to account for this variation and test for differences among the three groups
- Selection of participants
- Moderate. comparison group: non-randomised; participants self-selected the clinic and the treatment option with advice from a practitioner at screening
every individual received a 15 min screening with one of the practitioners (please note, this was neither of the authors of the current study) who recommended the best course of action for his/her needs
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Serious. only people who finished were analysed
Four cases contained substantial amounts of missing data; therefore these were excluded from the analysis (one individual from the nutrition group and three from the combined group).
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- NI. whether this outcome was pre-specified isn't reported
Side effects
No study of this treatment alone reported side effects we could read.
All papers
- Impact of Nutritional Therapy during Intensive Care Unit Admission on Post-Intensive Care Syndrome in Patients with COVID-19.2025 · compared with another group · 220 in the study
- A preliminary prospective study of nutritional, psychological and combined therapies for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in a private care setting.2012 · compared with another group · 145 in the study · 142 started · 138 with outcome data
- Post-Acute COVID-19 Syndrome in a 17-Year-Old: A Wolf in Sheep's Clothing2023 · case report · 1 in the study
Summary
This case report described one 17-year-old girl referred to a pulmonary out-patient clinic two months after positive SARS-CoV-2 testing with severe post-acute Covid-19 symptoms. She received methylprednisolone 1 g per day over five days, plus daily physiotherapy including breathing guidance, counselling by a psychologist and a dietary adviser. There was no comparison group; outcomes were observed before and after treatment. The report described clinical symptoms, remaining symptoms at follow-up two weeks and three months after discharge, and dyspnoea and pulmonary restriction under physiotherapeutic training. Clinical symptoms regressed rapidly after the five-day course of methylprednisolone; therapy was well tolerated and showed prompt improvement in all relevant areas; the patient remained asymptomatic after rehabilitation treatment; follow-up examinations gave no evidence for remaining clinical symptoms; and symptoms were rapidly and almost completely regressive under methylprednisolone. Perceptible improvement of dyspnoea and pulmonary restriction under physiotherapeutic training was also reported. The authors state that rare post-infectious conditions like this are hardly recognized, and that long-term bed confinement and weight loss may have contributed to the reduced condition at hospitalization.
- Life-Threatening Malnutrition in Very Severe ME/CFS.2021 · case report · 5 in the study
Summary
This paper reports five case reports from members of the 25% ME Group who had experience of being enterally or parenterally fed. The patients had very severe ME/CFS and received tube feeding by nasogastric tube, nasojejunal tube, percutaneous endoscopic gastrostomy or total parenteral nutrition; duration was not reported. There was no comparison group. The paper reports MUST score, BMI, weight, quality of life, ability to remove or reinsert an NGT, patients’ ratings and harms. In Case 1, MUST score was 4 and two months later with an established NGT feeding regime was still 2; she later had an improvement in quality of life with a HENS dietician and today has a normal BMI. In Case 2, BMI was 11.4, was 13.8 on discharge from hospital and is currently 18.6; medication for MCAD stabilized and then increased weight. In Case 5, BMI fell to 14.8 and is currently 20.5; she was able to remove the NGT but still required ONS, and was taught to reinsert an NGT at home. All patients felt supported by their HENS dietician. In one case enteral feeding was no longer required; in another dietary changes ameliorated suffering. Reported harms included tube blockage needing emergency replacement, pain whilst being fed, a PICC line infection, further weight loss with vomiting and abdominal pain during a trial of NGT feeding, the same effects with an NJT, and further weight loss despite TPN. The authors state limitations.
- Holistic Healing of Chronic Fatigue Syndrome: A Case Study On Ayurvedic, Dietary, And Yogic Interventions2025 · combination: given with other treatments · 1 in the study
Summary
This case study explored Ayurvedic treatment, dietary modifications, and yogic interventions for CFS, described as a debilitating disorder with prolonged unexplained fatigue, cognitive dysfunction, sleep disturbances, and musculoskeletal pain, and limited conventional options. The study involved a single 38-year-old male patient diagnosed with CFS. He underwent comprehensive assessment using laboratory tests, hormonal profiling, and imaging techniques. The intervention combined Ayurvedic formulations, a customized diet plan, and a structured yoga regimen including pranayama and meditation. The text reports no comparison group, no randomisation, and no treatment duration. Efficacy was evaluated using subjective and objective measures before and after the intervention. The authors report significant improvement in fatigue levels and overall quality of life. No side effects, withdrawals, or harms are reported. The paper does not report a follow-up period. The authors conclude that the combination proved effective in alleviating CFS symptoms and state that further research with larger sample sizes is warranted to establish standardized protocols.
- Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment.2024 · review
Summary
This literature review searched EBSCOhost Academic Search Premier, Proquest, Google Scholar, and the Cochrane Library in June 2022 for published treatments for chronic inflammatory response syndrome (CIRS), ME/CFS, and sick building syndrome. No patients were enrolled by the review; no comparison group, randomization, or follow-up duration was reported. The review reports 13 articles comprising 14 studies on CIRS treatment and also reviews CFS treatment studies. Named CIRS study sizes included 8, 13, 28, 14, 21, 156/111, 20, 35/4, 100, and 68/23. The review states the only treatment with documented clinical efficacy was the Shoemaker Protocol, described in 11 of the 13 articles; table entries list cholestyramine and vasoactive intestinal peptide as successful, while Rea’s antigen intradermal treatments had lack of objective data. CFS studies listed sizes including 49, 1518, 1030, 2036, 62, 409, 101, 171, 33, 32/18, 23, and 218; findings included some benefit for aripiprazole in 101 patients, high frequency of response for low-dose naltrexone in 218, and CBT/GET reported beneficial in six studies but noncurative. Reported side effects include constipation from cholestyramine, hyponatremia from desmopressin, and light-headedness from vasoactive intestinal peptides; medication intolerance was a barrier.